n-Lorem Podcast: Bottling Hope with CEO Wayne Woodard
In this n-Lorem podcast episode, Bottling Hope, host Stan Crook introduces guest Wayne Woodard, CEO of Argonaut. Wayne details his background in industrial technology, emphasizing
In this n-Lorem podcast episode, Bottling Hope, host Stan Crook introduces guest Wayne Woodard, CEO of Argonaut. Wayne details his background in industrial technology, emphasizing
Argonaut Manufacturing Services in a Molecule to Market Podcast Episode In the podcast series Molecule to Market, Raman Sehgal interviews influential leaders in the biopharmaceutical
Argonaut Manufacturing Services Expands Manufacturing Partnerships with Rare Disease Organizations CARLSBAD, CA March 08, 2023— Argonaut Manufacturing Services, a contract development and manufacturing organization (CDMO)
What can we learn from last year’s biotech/pharma manufacturing As the JPM meeting of 2023 closes, what can we learn from the last year and
Expanding drug product fill/finish capabilities Carlsbad, CA, 10th January 2023 – Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the life sciences, molecular
Updated October 16, 2022 In 2008-2010, the economic downturn in biotech wreaked havoc on the unprepared industry. Fast forward to late 2022, and the economic
Launch of LyoDots – World’s Smallest Lyophilized Reagents Carlsbad, CA, 7/26/22 – Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the biopharma, life
Simplify Molecular Assays with BioFuse Sample Prep Device Carlsbad, CA, 7/25/22 – Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the biopharma, life
Opinion: Wayne Woodard, CEO Argonaut Manufacturing Services Molecular Diagnostic Manufacturing in USA In early September 2020, I wrote an opinion piece titled “Bring Manufacturing Back
EUA Status for COVID-19 – Getting Back to Normal Operations The FDA recently recommended that “manufacturers of devices authorized under EUA’s (to) plan now, while